Senseonics Holdings (SENS) EBIT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 20.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 90.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -18.12% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 46.60% |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | -136.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -136.11% |
| Dec 31, 2025 | -46.63% |
| Sep 30, 2025 | 14.21% |
| Jun 30, 2025 | 26.52% |
| Mar 31, 2025 | 26.02% |
| Dec 31, 2024 | 16.07% |
| Sep 30, 2024 | -20.11% |
| Jun 30, 2024 | 1.89% |
| Mar 31, 2024 | 7.49% |
| Dec 31, 2023 | 9.85% |
| Sep 30, 2023 | -8.27% |
| Jun 30, 2023 | -16.62% |
| Mar 31, 2023 | -30.01% |
| Dec 31, 2022 | -35.25% |
| Sep 30, 2022 | -9.59% |
| Jun 30, 2022 | -7.21% |
| Mar 31, 2022 | -33.97% |
| Dec 31, 2021 | -35.31% |
| Sep 30, 2021 | -28.58% |
| Jun 30, 2021 | -26.86% |
| Mar 31, 2021 | 74.18% |
| Dec 31, 2020 | 70.45% |
| Sep 30, 2020 | 60.25% |
| Jun 30, 2020 | 63.85% |
| Mar 31, 2020 | -47.24% |
| Dec 31, 2019 | -21.90% |
| Sep 30, 2019 | -36.51% |
| Jun 30, 2019 | -72.71% |
| Mar 31, 2019 | -86.90% |
| Dec 31, 2018 | -82.59% |
| Sep 30, 2018 | -38.36% |
| Jun 30, 2018 | -72.36% |
| Mar 31, 2018 | -28.47% |
| Dec 31, 2017 | -65.94% |
| Sep 30, 2017 | -57.96% |
| Jun 30, 2017 | -0.79% |
| Mar 31, 2017 | -13.44% |
| Dec 31, 2016 | -15.30% |
| Sep 30, 2016 | -26.42% |
| Jun 30, 2016 | -67.20% |
| Mar 31, 2016 | -102.41% |